David Russler-Germain

24PUBLICATIONS
178CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Medical virologyPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Aug 14, 2026
Mosunetuzumab With Response-Adapted Polatuzumab Vedotin and Obinutuzumab in Untreated Indolent B-Cell Non-Hodgkin Lymphoma.

|May 27, 2026
Chimeric antigen receptor T-cell therapy and cardiovascular outcomes in US Medicare beneficiaries.

|Oct 27, 2025
Cell-of-Origin Subtype Predicts Response to Polatuzumab Vedotin in Large B-cell Lymphoma.

Edward R Scheffer Cliff, Guido D Pelaez, Fei Wan

|Apr 17, 2025
Prevalence of medical writing in hematological malignancy review articles.

Héctor A Vaquera-Alfaro, Elham Nasrollahi, Yashvin Onkarappa Mangala

|Mar 12, 2025
Memory-like NK cell differentiation, inhibitory NKG2A blockade, and improved recognition via antibody or CAR engineering combine to enhance NK cell attack against multiple myeloma.

Alice Y Zhou, Nancy D Marin, Sadia Afrin

|Jul 25, 2024
US Food and Drug Administration's Directive to Deal With Delayed Confirmatory Trials: Lessons From Pralatrexate and Belinostat for T-Cell Lymphoma.

Edward R Scheffer Cliff, David A Russler-Germain, C Joseph Ross Daval

Pageof 4

Frequent Collaborators

8 joint publications

Todd A Fehniger

7 joint publications

Marcus P Watkins

7 joint publications

Obi L Griffith

7 joint publications

Pamela Wong